{"id":"W2913987637","doi":"10.1200/jco.18.00915","title":"DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":264,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Cégep de l'Outaouais; McGill University","funders":"Verastem Oncology","keywords":"Medicine; Internal medicine; Refractory (planetary science); Neutropenia; Tolerability; Rituximab; Adverse effect; Lymphoma; Gastroenterology; Nausea; Oncology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001191641,0.0008010612,0.001264497,0.0002947671,0.0002111698,0.0008022215,0.0005817098,0.0005798151,0.001715491],"category_scores_gemma":[0.0005537162,0.0004109545,0.000595696,0.0002514614,0.0006709427,0.0005766829,0.0003323456,0.001522136,0.0004141625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00057058,"about_ca_system_score_gemma":0.001111762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006200815,"about_ca_topic_score_gemma":0.001708997,"domain_scores_codex":[0.9997881,0.0001085945,0.00001120105,0.00002935068,0.00002091662,0.0000419192],"domain_scores_gemma":[0.9996502,0.00005501781,0.00005950302,0.00002197264,0.00001689669,0.0001963835],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6292135,0.07473941,0.02519104,0.002223638,0.001808912,0.000498645,0.0006244644,0.003105436,0.07985248,0.0006836191,0.005683873,0.176375],"study_design_scores_gemma":[0.6802641,0.2844582,0.02214536,0.00005854223,0.0005343924,0.0005829562,0.000144935,0.00181963,0.004342415,0.0002217227,0.005384879,0.00004282514],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933174,0.00286229,0.0004163009,0.000234375,0.00006688127,0.001277742,0.0004810593,0.00008687181,0.001257125],"genre_scores_gemma":[0.9914834,0.001933469,0.001233433,0.0006225887,0.0001065796,0.001531108,0.001655303,0.00001864266,0.00141534],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001715491,"threshold_uncertainty_score":0.006302118,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04454469984713691,"score_gpt":0.4284871544306216,"score_spread":0.3839424545834846,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}